首页> 外文期刊>American Journal of Medicine and Medical Sciences >Diastolic Function of the Left Ventricle Depending on the Degree of Renal Dysfunction in the Background of Treatment
【24h】

Diastolic Function of the Left Ventricle Depending on the Degree of Renal Dysfunction in the Background of Treatment

机译:治疗背景下取决于肾功能不全程度的左心室舒张功能

获取原文
           

摘要

Background: To study the effect of lisinopril and losartan on the diastolic function of the left ventricle in patients with chronic heart failure (CHF), depending on the degree of renal dysfunction (RD). Materials and methods: A total of 223 patients with I-III FC of CHF were examined, initially and after 6 months. The first group consisted of 118 patients taking lisinopril as part of standard therapy; the second group - 105 - losartan. All patients were distributed depending on the estimated of the glomerular filtration rate (eGFR): 30 < eGFR ≤60 - 67 patients and eGFR > 60 ml / min / 1,73m~(2) -156 patients. Results: The analysis of baseline diastolic function in patients with CHF revealed diastolic dysfunction in 81,8% of patients with CHF, with a predominance of delayed relaxation in 59,3% of patients and an increase in the number of patients with a restrictive type of diastolic dysfunction in patients with III FC of CHF. The dependence between the parameters of the diastolic function - the rate of E and eGFR was revealed. Patients of the first and second groups with I-III FC of CHF after 6 months of treatment had an improvement in diastolic left ventricle function with advantage in patients in the group of losartan with I and III FC of CHF. On the background of treatment in patients with CHF with eGFR≤60 ml/min/1,73 m~(2) there was a significant increase in the rate of E in both groups of patients without statistically significant differences. Conclusion: Patients of the first and second groups with I-III FC of CHF after 6 months of treatment had an improvement in diastolic function left ventricle.
机译:背景:研究赖诺普利和氯沙坦对慢性心力衰竭(CHF)患者左心室舒张功能的影响,具体取决于肾脏功能障碍(RD)的程度。材料和方法:最初和之后6个月共检查了223例CHF的I-III FC患者。第一组包括118名接受赖诺普利作为标准疗法一部分的患者。第二组-105-氯沙坦。根据估计的肾小球滤过率(eGFR)分配所有患者:30 60 ml / min / 1,73m〜(2)-156患者。结果:对CHF患者的基线舒张功能的分析显示,有81.8%的CHF患者发生舒张功能障碍,其中59.3%的患者延迟舒张为主要症状,而限制性类型的患者数量有所增加CHF的III FC患者的舒张功能障碍舒张功能的参数之间的依赖性-E和eGFR的比率被揭示。在经过6个月的治疗后,第一组和第二组患有CHF的I-III FC的患者的舒张期左心室功能有所改善,在洛沙坦组具有CHF的I和III FC的患者中具有优势。在eGFR≤60ml / min / 1,73 m〜(2)的CHF患者的治疗背景下,两组患者的E率均显着升高,但无统计学差异。结论:第一组和第二组的CHF I-III FC患者在治疗6个月后左心室舒张功能得到改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号